Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome

Abstract Background Sjögren’s syndrome is a systemic autoimmune disease characterized by immune cells predominantly infiltrating the exocrine glands and frequently forming ectopic lymphoid structures. These structures drive a local functional immune response culminating in autoantibody production an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Estelle Gerossier, Saba Nayar, Sylvie Froidevaux, Charlotte G. Smith, Celine Runser, Valentina Iannizzotto, Enrico Vezzali, Gabin Pierlot, Ulrich Mentzel, Mark J. Murphy, Marianne M. Martinic, Francesca Barone
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Sjögren’s syndrome Sphingosine-1-phosphate receptor type 1 Animal models Immunomodulation Cenerimod Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/61ff86a6cb164b9daf9e959da2dde53e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome

Ejemplares similares